Home R&D Page 11

R&D

New therapeutic opportunity

Mechanisms of acquired resistance to anti-EGFR targeted therapies in metastatic colorectal...

Here is an extract of the doctoral thesis whereby Sandra Misale received the award "Marisa Colbacchini" established by Asis (Associazione Studi sull'Industria della Salute) and Carlo Erba Foundation for PhD researchers in oncology
Pharmaceutical raw materials

A special chance for innovation and investments

The unique macroeconomical framework should help the Italian manufacturers of pharmaceutical raw materials to strengthen their leading position in the field. Investments and institutional support is needed to overcome the bottlenecks that still slow down foreign investments in Italy. The president of Aschimfarma Gian Mario Baccalini comments the current trends.

Italy leader in the regenerative medicine field with Holoclar

The collaboration between public research and a private pharmaceutical enterprise has reached an amazing achievement “made in Italy”: the first drug based on stem cells authorized in Europe
Formulation technology

A question of taste

The taste of medicinal products is an important feature to be considered, especially while developing oral formulations for the paediatric population. Taste masking needs to take into consideration the preferences of different age groups in order to end up with an attractive formulation

Clinical trials. Which patients do we include?

We are moving towards a drug development approach patient focused. Can we offer new innovative therapies to severe patients and ethnic minorities?
Nicholas A. Peppas

Excellence in drug delivery

The famous scientist has a long history of innovation in biomedical engineering, drug delivery and controlled release systems. He has been awarded the Giulio Natta Medal in Chemical Engineering by the Politecnico of Milan